Skip to main content
Journal of Cellular and Molecular Medicine logoLink to Journal of Cellular and Molecular Medicine
. 2023 Sep 1;27(22):3646–3647. doi: 10.1111/jcmm.17887

Corrigendum

PMCID: PMC10660635  PMID: 37655639

In Zhang et al., 1 the published article contains errors in Figure 5A,B. The correct figures are shown below. The authors confirm all results and conclusions of this article remain unchanged.

FIGURE 5.

FIGURE 5

Effects of Rb1 on macrophage polarisation in atherosclerotic lesions of ApoE−/−mice. (A, B) Representative images of MOMA‐2+iNOS+ and MOMA‐2+Arg‐1+ macrophages in situ in control group (NC) and Rb1 treatment group (Rb1). (C, D) Statistics of the number of MOMA‐2+iNOS+ and MOMA‐2+Arg‐1+ macrophages in atherosclerotic lesions in control group (NC) and Rb1 treatment group (Rb1). Scale bar: 20 μm. *p < 0.05; n = 6. (E) Representative immunoblots of iNOS (M1 marker) and Arg‐1 (M2 marker) in vivo. (F) Statistics of iNOS and Arg‐1 expression relative to the β‐actin level. Data were presented as means ± S.D.; *p < 0.05, compared to control group; n = 3.

The authors apologize for the inconvenience this may cause.

REFERENCE

  • 1. Zhang X, Liu MH, Qiao L, et al. Ginsenoside Rb1 enhances atherosclerotic plaque stability by skewing macrophages to the M2 phenotype. J Cell Mol Med. 2018;22:409‐416. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Cellular and Molecular Medicine are provided here courtesy of Blackwell Publishing

RESOURCES